Phlexglobal Launches Career Development Training Curriculum
Phlexglobal has launched a new training curriculum for CRAs, CTAs, and document managers which addresses the growing requirement for a branded mix of knowledge and skills across the roles.
The new training curriculum was established to help meet Good Clinical (Research) Practice legislation on research.
European Head of Training at Phlexglobal, Dr. Gareth Hayes, explained: "The emphasis has been on quantity and speed rather than quality and effectiveness. This has been recognized by the authorities with audit and inspection findings constantly identifying inappropriately placed personnel whose roles outstretch their capabilities."
"Transferable skills are essential behavioural components that Phlexglobal recognizes as crucial in order to satisfy the demands of the job, whether as a CRA, CTA, or document manager. They are highly marketable because they are needed for a wide variety of jobs and can be transferred from one task, job, or workplace to another."
Phlexglobal is a specialist global CRO which delivers clinical research support solutions to meet its clients’ needs through its five core services of resourcing, task force, clinical support services, eTMF, and document solution and training. It works across the pharmaceutical, biotechnology, medical device, CRO and healthcare industries.
The three core groups, focus on people skills, practical skills, and adaptability skills, and combine with role-specific GCP training (from site responsibilities to TMF architecture).
All Phlexglobal’s training can be either delivered at its headquarters in Amersham or in-house at the client’s office.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
